本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

473.79
-7.2100-1.50%
盤後473.790.00000.00%17:01 EST
成交量:25.64萬
成交額:1.22億
市值:107.60億
市盈率:-36.35
高:484.25
開:483.90
低:468.08
收:481.00
52周最高:615.00
52周最低:265.00
股本:2,271.14萬
流通股本:1,100.01萬
量比:0.69
換手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
淨資產收益率:-41.22%
總資產收益率:-15.78%
市淨率:17.20
市盈率(LYR):-21.63

資料載入中...

公司資料

公司名字:
Madrigal Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
528
公司地址:
Four Tower Bridge,Suite 200,200 Barr Harbor Drive,West Conshohocken,Pennsylvania,United States
郵編:
19428
電話:
傳真:
- -
簡介:
Madrigal Pharmaceuticals, Inc.於2000年3月成立並在2001年7月開始運營。 Synta製藥公司是一家生物製藥公司,致力於發現、開發和商業化小分子藥物以擴大和加強帶有嚴重疾病的患者的生命,包括癌症和慢性症性疾病。該公司有兩種候選藥物在臨床實驗中用於治療多種類型的癌症和幾個用於臨床前研究階段的候選藥物。所有公司的候選藥物利用公司的專利、獨特的化合物和集成的發現引擎發現。這家公司保留了其候選藥物的全部選擇權。

董事

名稱
職位
Bill Sibold
President and Chief Executive Officer and Director
Julian C. Baker
Independent Chairman of the Board and Independent Director
Jacqualyn A. Fouse
Independent Director
James M. Daly
Independent Director
Kenneth M. Bate
Independent Director
Paul A. Friedman
Independent Director
Raymond Cheong
Independent Director
Richard S. Levy
Independent Director
Rebecca Taub
Director

股東

名稱
職位
Bill Sibold
President and Chief Executive Officer and Director
Mardi Dier
Executive Vice President and Chief Financial Officer
Rita Thakkar
Senior Vice President and Chief Accounting Officer
Carole Huntsman
Executive Vice President and Chief Commercial Officer
David Soergel
Executive Vice President and Chief Medical Officer
Shannon Kelley
Executive Vice President and Chief Legal Counsel